Greg Norden has served as a member of our board of directors since March 2019. Mr. Norden is the former Chief Financial Officer of Wyeth and currently serves as the Managing Director of G9 Capital Group LLC, which invests in early stage ventures and provides corporate advisory services. Mr. Norden currently serves on the boards of directors of Zoetis (NYSE: ZTS), the world’s leading animal health company, NanoString Technologies (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Royalty Pharma (NASDAQ: RPRX), a leading funder of innovation across the biopharmaceutical industry. Mr. Norden is a former director of Human Genome Sciences, Univision and Welch Allyn. Mr. Norden received a B.S. in Management and Economics from the State University of New York at Plattsburgh and an M.S. in Accounting from LIU Post.